OB-GYN Dr. DeShawn Taylor shares her concerns about the December court case that could roll Arizona back to its pre-statehood abortion ban.
OPINION: If it were up to Speaker Johnson, doctors like myself would be thrown in prison and sentenced to hard labor for serving our patients.
These wins indicate that reproductive rights remain a potent issue for voters heading into the 2024 presidential election.
The current law prohibits abortions related to genetic abnormalities of any kind, even if the pregnancy puts the life of the mother or the fetus or embryo at risk.
Although these pharmacies dispensing the drug marks a victory for reproductive freedom, a looming Supreme Court case could cut off access to the medication in states where abortion is still legal.
Opill is the first ever birth control pill to be approved for over-the-counter sales. The medication will likely become available at stores and online retailers in the U.S. in early 2024.
Women have suffered through ectopic pregnancies, miscarriages, fetal anomalies, and other complications, but have found it difficult to get the care they need due to restrictive abortion bans.
The 5th Circuit’s ruling maintains mifepristone’s availability for now, but severely limits access in ways that could harm patients seeking abortion care.
Access to the abortion medication mifepristone has been called into question following the issuance of competing rulings in Texas and Washington.
